Director Nina Armagno filed a Form 144 notice of proposed sale of 10,926 shares of Rocket Lab Corporation common stock on November 2, 2026, pursuant to Rule 144 under the Securities Act of 1933.

Key Highlights

  • Seller: Nina Armagno, identified in the filing as a Director of Rocket Lab Corporation.
  • Shares proposed for sale: 10,926 shares of common stock, with an aggregate market value of $597,979.98.
  • Source of shares: Restricted Stock Units acquired from the issuer on October 30, 2026.
  • Approximate sale date: November 2, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
  • Shares outstanding: 598,350,482 shares of common stock reported outstanding as of the filing date.
  • Rule 10b5-1 plan: The filing indicates a plan adoption date of September 19, 2025.
  • Prior three-month sales: The filing reports nothing to report for securities sold during the past three months.

Nina Armagno's Proposed Sale Under a Rule 10b5-1 Plan at Rocket Lab

According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, Rocket Lab Corporation director Nina Armagno provided notice of a proposed sale of 10,926 shares of the company's common stock. The filing lists the issuer's address as 3881 McGowen Street, Long Beach, California 90808, and identifies Rocket Lab's securities as trading on NASDAQ. The SEC file number listed in the filing is 001-39560.

The filing discloses that the 10,926 shares were acquired as Restricted Stock Units from the issuer on October 30, 2026, with the date of payment also listed as October 30, 2026. The aggregate market value of the shares proposed to be sold is stated as $597,979.98. The broker named for the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services. The filing notes that no securities of the issuer were sold by Armagno during the three months preceding this notice.

The filing indicates that Armagno is relying on Rule 10b5-1 of the Exchange Act, with a plan adoption date of September 19, 2025. By signing the form, the filer represented, as of the plan adoption date, that she did not know of any material adverse information regarding the current and prospective operations of the issuer that had not been publicly disclosed, according to the attestation language contained in the notice.

What Was Disclosed

Rocket Lab Corporation director Nina Armagno filed a Form 144 on November 2, 2026, proposing the sale of 10,926 common shares valued at $597,979.98, acquired via Restricted Stock Units on October 30, 2026, under a Rule 10b5-1 plan adopted September 19, 2025.